the product in the database has an inactive status
indications:
Occasional constipation (for short-term use).
Composition:
1 tabl the sachete contains 83.3 mg of dry extract from the buckthorn bark, corresponding to 10-15 mg of hydroxyanthraquinic glycosides based on glucofrangulin A.
Action:
Preparation of natural origin with a laxative effect. It stimulates the motility of the large intestine, which leads to acceleration of the passage of intestinal contents. It affects secretory processes (stimulation of secretion of mucus and chlorides), which leads to increased secretion of fluids into the intestinal lumen. Defecation usually occurs about 8-12 hours after taking the drug.
Contraindications:
Hypersensitivity to the components of the preparation. Intestinal obstruction and intestinal stenosis, intestinal atony, appendicitis, inflammatory diseases of the large intestine (e.g., Crohn's disease, ulcerative colitis). Abdominal pain of unknown origin. Severe dehydration with water and electrolyte deficiency. Children under 12 years.
Precautions:
It should not be used in patients who are afflicted with faecal or undiagnosed, acute or persistent gastrointestinal complaints, such as abdominal pain, nausea and vomiting. Buckthorn bark preparations should only be used if the therapeutic effect can not be achieved by changing the diet or by using agents that increase the volume of faeces. In patients with impaired renal function, the use of bucolic bark preparations may cause electrolyte disturbances. Patients with rare hereditary disorders associated with fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase deficiency should not take the preparation. Due to the content of the dye, yellowish orange, hypersensitivity reactions may occur.
Pregnancy and lactation:
The use of bovine bark preparations in pregnant women and during breastfeeding is not recommended.
Side effects:
Hypersensitivity reactions, systolic abdominal pain, liquid stools, especially in patients with sensitive myelosis may occur. Chronic use may lead to water-electrolyte disorders, albuminuria, hematuria and may cause pigment changes in the intestinal mucosa, which usually disappears after discontinuation of the preparation. During the application of the preparation, yellow or red-brown urine may appear.
Dosage:
Orally. Adults and children over 12 years: 1-2 tabl., Drink water. The maximum daily dose of hydroxyanthasine glycosides is 30 mg. The maximum treatment time is 1-2 weeks.
(C)
